NANOG and hepatocellular carcinoma: Based on established relationships between β-CATENIN and NANOG-downstream gene YAP1 in upregulating BIRC5 (37, 38), we evaluated relationships between BIRC5, β-CATENIN, and NANOG expression levels with poor HCC prognosis or malignant transformation of HCC development.